We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » 483 Roundup: FDA Cites Five Drugmakers for GMPs, Other Issues
483 Roundup: FDA Cites Five Drugmakers for GMPs, Other Issues
The FDA hammered five drug manufacturers — one Indian and four American — for varying issues at their drug making facilities, sending the companies Form 483s for their violations.